This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Lactated Ringers

Read time: 1 mins
Marketing start date: 12 Jan 2025
...
 

Summary of product characteristics


Effective Time

20241203

Version

1

Spl Product Data Elements

Lactated Ringers Sodium chloride, potassium chloride, sodium lactate and calcium chloride SODIUM CHLORIDE SODIUM CATION CHLORIDE ION SODIUM LACTATE SODIUM CATION LACTIC ACID, UNSPECIFIED FORM POTASSIUM CHLORIDE POTASSIUM CATION CHLORIDE ION CALCIUM CHLORIDE CHLORIDE ION WATER

Brand Name

Lactated Ringers

Generic Name

Sodium chloride, potassium chloride, sodium lactate and calcium chloride

Product Ndc

0338-9832

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAVENOUS

Package Label Principal Display Panel

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL Baxter Logo Trademark A6E2323 SODIUM LACTATE RINGER’S INJECTION 100 200 300 400 500ml [Strength] 500ml Each 500ml contains 1.55g Sodium Lactate, 3.00g Sodium Chloride, 0.15g Potassium Chloride, and 0.10g Calcium Chloride Dihydrate [Description] This product is a clear, colorless liquid [Dosage and Administration] Intravenous drip See the package insert for details For details of [Indications], [Adverse Reactions], [Contraindications], and [Precautions], please refer to the package insert [Storage] Store in overwrap The solution should be clear and should be used up at one time Inspect the inner bag by squeezing it and discard solution if leakage occurs License Number: H19983144 [Drug Marketing Authorization Holder] [Manufacturer] Name: Baxter Healthcare (Shanghai) Co., Ltd. Address: No. 388, Tingzhu Road, Jinshan District, Shanghai LOT MFG EXP Lactated Ringer Representative Carton Label 500ml Chinese.jpg

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.